Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $656.15 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tris Pharma Inc | $213.96 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $185.83 | 2 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $166.90 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $46.21 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $26.44 | 1 | $0 (2023) |
| CSL Behring | $16.81 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88.96 | 1 | Tris Pharma Inc ($88.96) |
| 2023 | $102.44 | 4 | Otsuka America Pharmaceutical, Inc. ($46.21) |
| 2022 | $339.77 | 4 | Neurocrine Biosciences, Inc. ($137.11) |
| 2021 | $124.98 | 1 | Janssen Pharmaceuticals, Inc ($124.98) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2024 | Tris Pharma Inc | Dyanavel XR (Drug), Quillivant, Quillichew ER | Food and Beverage | In-kind items and services | $88.96 | General |
| Category: ADHD | ||||||
| 10/05/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: PSYCHIATRY | ||||||
| 09/22/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Neurology | ||||||
| 08/04/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: PSYCHIATRY | ||||||
| 05/05/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/27/2022 | Tris Pharma Inc | Dyanavel XR (Drug), Quillivant, Quillichew ER | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ADHD | ||||||
| 07/26/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $137.11 | General |
| Category: Neuropsychiatry | ||||||
| 02/22/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $60.85 | General |
| Category: Neuroscience | ||||||
| 10/27/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 28 | 41 | $10,795 | $2,480 |
| 2022 | 3 | 50 | 76 | $16,812 | $4,054 |
| 2021 | 3 | 61 | 78 | $16,138 | $4,758 |
| 2020 | 4 | 85 | 101 | $26,016 | $6,028 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 13 | 13 | $5,538 | $1,349 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 28 | $5,257 | $1,130 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 34 | $8,154 | $1,790 | 22.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 11 | 11 | $3,615 | $1,143 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 31 | $5,043 | $1,121 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 29 | $6,757 | $1,887 | 27.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 26 | 38 | $6,004 | $1,551 | 25.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 11 | 11 | $3,377 | $1,320 | 39.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 42 | $9,786 | $2,155 | 22.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 20 | 20 | $6,240 | $1,503 | 24.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $5,882 | $1,496 | 25.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 20 | 26 | $4,108 | $873.60 | 21.3% |
About Phil Johns, PA
Phil Johns, PA is a Health & Wellness Coach healthcare provider based in Cornelius, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1841432549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Phil Johns, PA has received a total of $656.15 in payments from pharmaceutical and medical device companies, with $88.96 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($656.15).
As a Medicare-enrolled provider, Johns has provided services to 224 Medicare beneficiaries, totaling 296 services with total Medicare billing of $17,319. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Health & Wellness Coach
- Other Specialties Physician Assistant, Physician Assistant
- Location Cornelius, NC
- Active Since 03/27/2009
- Last Updated 12/26/2024
- Taxonomy Code 171400000X
- Entity Type Individual
- NPI Number 1841432549
Products in Payments
- Dyanavel XR (Drug) $213.96
- INVEGA SUSTENNA (Drug) $185.83
- INGREZZA (Drug) $166.90
- UZEDY (Drug) $26.44
- ABILIFY MAINTENA (Drug) $26.17
- ABILIFY ASIMTUFII (Drug) $20.04
- Kcentra (Biological) $16.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.